Global and China Enteric Disease Testing Industry Ecological Development and Analysis Report 2023

Length- 106 Pages | Published Date - 2022-11-15 | Report Id- 4178
Single Licence $3100.00 | Enterprise License $5600.00 | Multiple Licensee $5600.00
This report aims to provide a comprehensive presentation of the global market for Enteric Disease Testing, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enteric Disease Testing.

The Enteric Disease Testing market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Enteric Disease Testing market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enteric Disease Testing manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Enteric Disease Testing market size in 2022 is 1954.26 million US dollars, and it is expected to be 2959.90 million US dollars by 2029, with a compound annual growth rate of 6.11% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Enteric Disease Testing market include 3M, ALS Limited, Asure Quality, Becton Dickinson, and Bio-Rad Laboratories, Inc.. The share of the top 3 players in the Enteric Disease Testing market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Enteric Disease Testing market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. E. coli accounted for XX% of Enteric Disease Testing market in 2022. Salmonella share of XX%.
Hospitals accounted for XX% of the Enteric Disease Testing market in 2022. Diagnostic Centres accounts for XX%.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico

Player list
3M
ALS Limited
Asure Quality
Becton Dickinson
Bio-Rad Laboratories, Inc.
Bureau Veritas
Eurofins Scientific
Hardy Diagnostics
Intertek
Merck Kgaa
Mérieux Nutrisciences
Neogen Corporation
PerkinElmer
SGS SA
Thermo Fisher Scientific Inc.

Types list
E. coli
Salmonella
Campylobacter
Listeria
Other pathogens

Application list
Hospitals
Diagnostic Centres
Others

Contact US Anytime

Contact US Anytime

Find More

Global and China Enteric Disease Testing Industry Ecological Development and Analysis Report 2023

Get a FREE sample

Have Requests? Need Customization? Our Research Team Will Help to Maximize Your "Interest Scope and Content Customization" into Our Analysis Report.

Custom Research
Dongguan Jianpeng Intelligent Technology Co., Ltd
top
Copyright © 2020-2025 Arsta Research All Rights Reserved
Technical support : Cssl
Choose a different language

Sample Request

Message